Table of Contents
ISRN Immunology
Volume 2011, Article ID 584682, 6 pages
http://dx.doi.org/10.5402/2011/584682
Research Article

Consumption of Galactooligosaccharides together with Probiotics Stimulates the In Vitro Peripheral Blood Mononuclear Cell Proliferation and IFNγ Production in Healthy Men

1Pharmacology, Institute of Biomedicine, University of Helsinki, P.O. Box 63, FIN-00014 Helsinki, Finland
2Valio Ltd., R&D, P.O. Box 30, FIN-00039 Helsinki, Finland
3STAT Consulting, Vahverokatu 6, FIN-37130 Nokia, Finland
4Immune Response Unit, Department of Vaccination and Immune Protection, National Institute for Health and Welfare, P.O. Box 104, FIN-00251 Helsinki, Finland
5Folkhälsan Research Center, University of Helsinki, Biomedicum, P.O. Box 63, FIN-00014 Helsinki, Finland

Received 29 August 2011; Accepted 20 September 2011

Academic Editors: A. Boon and C. Faveeuw

Copyright © 2011 Reetta Holma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Bourlioux, B. Koletzko, F. Guarner, and V. Braesco, “The intestine and its microflora are partners for the protection of the host: report on the danone symposium “the intelligent intestine,” held in Paris, June 14, 2002,” American Journal of Clinical Nutrition, vol. 78, no. 4, pp. 675–683, 2003. View at Google Scholar · View at Scopus
  2. H. Tlaskalová-Hogenová, R. Štěpánková, T. Hudcovic et al., “Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases,” Immunology Letters, vol. 93, no. 2-3, pp. 97–108, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Lu and W. A. Walker, “Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium,” American Journal of Clinical Nutrition, vol. 73, no. 6, pp. 1124S–1130S, 2001. View at Google Scholar · View at Scopus
  4. I. R. Sanderson, “Dietary modulation of GALT,” The Journal of Nutrition, vol. 137, no. 11, pp. 2557S–2562S, 2007. View at Google Scholar · View at Scopus
  5. S. Seifert and B. Watzl, “Inulin and oligofructose: review of experimental data on immune modulation,” The Journal of Nutrition, vol. 137, no. 11, pp. 2563S–2567S, 2007. View at Google Scholar · View at Scopus
  6. FAO/WHO, Report of a joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food, 2002ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.
  7. G. A. Preidis and J. Versalovic, “Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era,” Gastroenterology, vol. 136, no. 6, pp. 2015–2031, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. G. R. Gibson and M. B. Roberfroid, “Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics,” Journal of Nutrition, vol. 125, no. 6, pp. 1401–1412, 1995. View at Google Scholar · View at Scopus
  9. M. Roberfroid, G. R. Gibson, L. Hoyles et al., “Prebiotic effects: metabolic and health benefits,” The British Journal of Nutrition, vol. 104, supplement 2, pp. S1–S63, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Boirivant and W. Strober, “The mechanism of action of probiotics,” Current Opinion in Gastroenterology, vol. 23, no. 6, pp. 679–692, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Isolauri, Y. Sütas, P. Kankaanpää, H. Arvilommi, and S. Salminen, “Probiotics: effects on immunity,” American Journal of Clinical Nutrition, vol. 73, no. 2, pp. 444S–450S, 2001. View at Google Scholar · View at Scopus
  12. A. R. Lomax and P. C. Calder, “Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans,” Current Pharmaceutical Design, vol. 15, no. 13, pp. 1428–1518, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. G. T. Macfarlane, H. Steed, and S. Macfarlane, “Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics,” Journal of Applied Microbiology, vol. 104, no. 2, pp. 305–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. R. A. Kekkonen, R. Holma, K. Hatakka et al., “A probiotic mixture including galactooligosaccharides decreases fecal ß-glucosidase activity but does not affect serum enterolactone concentration in men during a two-week intervention,” The Journal of Nutrition, vol. 141, no. 5, pp. 870–876, 2011. View at Google Scholar
  15. E. E. McClelland and J. M. Smith, “Gender specific differences in the immune response to infection,” Archivum Immunologiae et Therapiae Experimentalis, vol. 59, no. 3, pp. 203–213, 2011. View at Google Scholar
  16. M. Halminen, P. Klemetti, O. Vaarala, M. Hurme, and J. Ilonen, “Interferon-γ production in antigen specific T cell response: quantitation of specific mRNA and secreted protein,” Scandinavian Journal of Immunology, vol. 46, no. 4, pp. 388–392, 1997. View at Google Scholar · View at Scopus
  17. E. Pohjavuori, M. Viljanen, R. Korpela et al., “Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy,” The Journal of Allergy and Clinical Immunology, vol. 114, no. 1, pp. 131–136, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Klemetti, P. Björses, T. Tuomi et al., “Autoimmunity to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED),” Clinical and Experimental Immunology, vol. 119, no. 3, pp. 419–425, 2000. View at Google Scholar · View at Scopus
  19. A. Billiau and P. Matthys, “Interferon-γ: a historical perspective,” Cytokine & Growth Factor Reviews, vol. 20, no. 2, pp. 97–113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. L. K. Teixeira, B. P. F. Fonseca, B. A. Barboza, and J. P. B. Viola, “The role of interferon-gamma on immune and allergic responses,” Memórias do Instituto Oswaldo Cruz, vol. 100, supplement 1, pp. 137–144, 2005. View at Google Scholar · View at Scopus
  21. S. L. Prescott, J. A. Dunstan, J. Hale et al., “Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis,” Clinical and Experimental Allergy, vol. 35, no. 12, pp. 1557–1564, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Kukkonen, E. Savilahti, T. Haahtela et al., “Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial,” The Journal of Allergy and Clinical Immunology, vol. 119, no. 1, pp. 192–198, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Kukkonen, E. Savilahti, T. Haahtela et al., “Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial,” Pediatrics, vol. 122, no. 1, pp. 8–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. R. A. Kekkonen, N. Lummela, H. Karjalainen et al., “Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults,” World Journal of Gastroenterology, vol. 14, no. 13, pp. 2029–2036, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Isolauri, J. Joensuu, H. Suomalainen, M. Luomala, and T. Vesikari, “Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by lactobacillus casei GG,” Vaccine, vol. 13, no. 3, pp. 310–312, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. M. V. Kopp, M. Goldstein, A. Dietschek, J. Sofke, A. Heinzmann, and R. Urbanek, “Lactobacillus GG has in vitro effects on enhanced interleukin-10 and interferon-gamma release of mononuclear cells but no in vivo effects in supplemented mothers and their neonates,” Clinical and Experimental Allergy, vol. 38, no. 4, pp. 602–610, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Ogué-Bon, C. Khoo, A. L. McCartney, G. R. Gibson, and R. A. Rastall, “In vitro effects of synbiotic fermentation on the canine faecal microbiota,” FEMS Microbiology Ecology, vol. 73, no. 3, pp. 587–600, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Hughes, Y. Davoodi-Semiromi, J. C. Colee et al., “Galactooligosaccharide supplementation reduces stress-induced gastrointestinal dysfunction and days of cold or flu: a randomized, double-blind, controlled trial in healthy university students,” The American Journal of Clinical Nutrition, vol. 93, no. 6, pp. 1305–1311, 2011. View at Google Scholar
  29. D. Bunout, S. Hirsch, M. P. de la Maza et al., “Effects of prebiotics on the immune response to vaccination in the elderly,” Journal of Parenteral and Enteral Nutrition, vol. 26, no. 6, pp. 372–376, 2002. View at Google Scholar · View at Scopus
  30. A. E. Flinterman, E. F. Knol, A. G. van Ieperen-Van Dijk et al., “Probiotics have a different immunomodulatory potential in vitro versus ex vivo upon oral administration in children with food allergy,” International Archives of Allergy and Immunology, vol. 143, no. 3, pp. 237–244, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. V. L. Miniello, L. Brunetti, R. Tesse, M. Natile, L. Armenio, and R. Francavilla, “Lactobacillus reuteri modulates cytokines production in exhaled breath condensate of children with atopic dermatitis,” Journal of Pediatric Gastroenterology and Nutrition, vol. 50, no. 5, pp. 573–576, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Spanhaak, R. Havenaar, and G. Schaafsma, “The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans,” European Journal of Clinical Nutrition, vol. 52, no. 12, pp. 899–907, 1998. View at Google Scholar · View at Scopus
  33. A. Marcos, J. Wärnberg, E. Nova et al., “The effect of milk fermented by yogurt cultures plus Lactobacillus casei DN-114001 on the immune response of subjects under academic examination stress,” European Journal of Nutrition, vol. 43, no. 6, pp. 381–389, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. H. R. Christensen, C. N. Larsen, P. Kæstel et al., “Immunomodulating potential of supplementation with probiotics: a dose-response study in healthy young adults,” FEMS Immunology and Medical Microbiology, vol. 47, no. 3, pp. 380–390, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. A. L. Meyer, I. Elmadfa, I. Herbacek, and M. Micksche, “Probiotic, as well as conventional yogurt, can enhance the stimulated production of proinflammatory cytokines,” Journal of Human Nutrition and Dietetics, vol. 20, no. 6, pp. 590–598, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Aldinucci, L. Bellussi, G. Monciatti et al., “Effects of dietary yoghurt on immunological and clinical parameters of rhinopathic patients,” European Journal of Clinical Nutrition, vol. 56, no. 12, pp. 1155–1161, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. R. L. Clancy, M. Gleeson, A. Cox et al., “Reversal in fatigued athletes of a defect in interferon gamma secretion after administration of Lactobacillus acidophilus,” British Journal of Sports Medicine, vol. 40, no. 4, pp. 351–354, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Roller, Y. Clune, K. Collins, G. Rechkemmer, and B. Watzl, “Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients,” The British Journal of Nutrition, vol. 97, no. 4, pp. 676–684, 2007. View at Publisher · View at Google Scholar · View at Scopus